Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

NCT00923013 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

175

Enrollment

NIH

Sponsor class

Conditions

Hairy Cell Leukemia

Interventions

DRUG: Cladribine
DRUG: Rituximab
PROCEDURE: BMbx
DIAGNOSTIC_TEST: MRI
DIAGNOSTIC_TEST: EKG
DIAGNOSTIC_TEST: Echocardiogram
DIAGNOSTIC_TEST: Abdominal/splenic ultrasound
PROCEDURE: Stress test

Sponsor

National Cancer Institute (NCI)